Glaucoma, Primary Open Angle Clinical Trial
Official title:
Glaucoma Assessment Via Reading Ability Using Logarithmic Chinese Reading Acuity Chart
Verified date | December 2022 |
Source | Peking University |
Contact | Chun Zhang |
Phone | 18301031059 |
zhangc1[@]yahoo.com | |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To explore a quantitative glaucoma evaluation tool of glaucoma through the dynamic evaluation of reading ability based on logarithmic Chinese reading acuity chart (C-READ), and investigate its feasibility.
Status | Not yet recruiting |
Enrollment | 200 |
Est. completion date | February 29, 2024 |
Est. primary completion date | December 31, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Primary open angle glaucoma in at least 1 eye or labelled as a glaucoma suspect by a glaucoma specialist - Age =18 years old - with open angles on gonioscopy - best-corrected visual acuity =0.5 - spherical refraction within ±5.0 diopters (D), and/or cylinder correction within 3.0 D Exclusion Criteria: - eyes with any evidence of physical abnormality of the iris or pupils on slit-lamp examination - eyes with a history of trauma or inflammation - undergone an intraocular surgery or laser within the previous 6 months/except uncomplicated cataract surgery - using systemic or topical medications that could affect pupil responses, including pilocarpine or atropine - presence of any media opacities that prevented good quality OCT or fundus images - presence of any retinal or neurological disease other than glaucoma - abnormal ocular motility that prevents binocular fixation (eg, nystagmus, strabismus) - with severe systemic diseases or psychiatric disorders |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Peking University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The Relationship between Reading Ability and C-READ Test Results | The Relationship between Reading Ability and C-READ Test Results | January 2023 to December 2023 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02679482 -
Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma
|
N/A | |
Recruiting |
NCT05999006 -
Safety and Feasibility of the ELIOS System in POAG Patients
|
N/A | |
Completed |
NCT05181046 -
Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients
|
N/A | |
Completed |
NCT01999348 -
A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting
|
||
Completed |
NCT04149899 -
Safety and IOP-Lowering Effects of WB007
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04007276 -
The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients
|
Phase 4 | |
Completed |
NCT01814761 -
A Study of Bimatoprost 0.01% in the Clinical Setting
|
Phase 4 | |
Active, not recruiting |
NCT04899063 -
Excimer Laser Trabeculostomy Glaucoma Treatment Study
|
N/A | |
Completed |
NCT05474716 -
The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA
|
Phase 4 | |
Recruiting |
NCT03067415 -
Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily
|
Phase 2 | |
Not yet recruiting |
NCT06053307 -
Treating Psychosocial Distress in Glaucoma
|
N/A | |
Terminated |
NCT02858284 -
Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension
|
N/A | |
Completed |
NCT02796560 -
Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
|
Phase 4 | |
Recruiting |
NCT05370287 -
Adaptive Optics Retinal Imaging
|
N/A | |
Active, not recruiting |
NCT03318510 -
LSFG in Patients With Normal Tension Glaucoma Tension Glaucoma
|
N/A | |
Active, not recruiting |
NCT03151577 -
Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent
|
N/A | |
Completed |
NCT04465864 -
Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert
|
Phase 4 | |
Recruiting |
NCT03675412 -
Caffeine Consumption in Glaucoma Patients and Healthy Subjects
|
N/A | |
Completed |
NCT01833741 -
A Study of LUMIGAN® RC in the Clinical Setting
|
Phase 4 | |
Completed |
NCT03800589 -
Assessment of Effectiveness Ex-Press Surgery Modification
|
N/A |